David A Spellman
First SEC filing: July 2, 2020 · Latest: July 2, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | AKBA | S | 63,567 | $1.07 | $68,017 | 446,483 Direct | -12.46% | Disposed | -19.2% (price as of 2026-10-02) |
| March 1, 2023 | AKBA | S | 6,400 | $0.88 | $5,632 | 510,860 Direct | -1.24% | Disposed | -1.7% (price as of 2026-10-02) |
| March 1, 2023 | AKBA | S | 810 | $0.88 | $713 | 510,050 Direct | -0.16% | Disposed | -1.7% (price as of 2026-10-02) |
| Feb. 27, 2023 | AKBA | S | 7,539 | $0.81 | $6,107 | 517,260 Direct | -1.44% | Disposed | 6.8% (price as of 2026-10-02) |
| Jan. 31, 2023 | AKBA | A | 196,200 | · | · | 524,799 Direct | +59.71% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2023 | AKBA | A | 294,300 | · | · | 294,300 Direct | · | Acquired | (price as of 2026-10-02) |
| June 8, 2022 | AKBA | A | 200,000 | · | · | 328,599 Direct | +155.52% | Acquired | (price as of 2026-10-02) |
| June 8, 2022 | AKBA | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2022 | AKBA | S | 803 | $2.17 | $1,743 | 128,599 Direct | -0.62% | Disposed | -60.1% (price as of 2026-10-02) |
| Feb. 28, 2022 | AKBA | S | 7,400 | $2.15 | $15,910 | 69,402 Direct | -9.64% | Disposed | -59.8% (price as of 2026-10-02) |
| Feb. 28, 2022 | AKBA | A | 60,000 | · | · | 129,402 Direct | +86.45% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2022 | AKBA | A | 225,000 | · | · | 225,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 30, 2021 | AKBA | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2021 | AKBA | S | 790 | $3.40 | $2,686 | 76,802 Direct | -1.02% | Disposed | -74.6% (price as of 2026-10-02) |
| March 16, 2021 | AKBA | A | 7,592 | · | · | 77,592 Direct | +10.85% | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2021 | AKBA | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2021 | AKBA | A | 120,000 | · | · | 120,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 30, 2020 | AKBA | A | 280,000 | · | · | 280,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 31, 2023 | AKBA | Stock Option (Right to buy) | Common Stock | $0.63 | Jan. 31, 2033 | 294,300 | Acquired |
| June 8, 2022 | AKBA | Stock Option (Right to buy) | Common Stock | $0.45 | June 8, 2032 | 200,000 | Acquired |
| Feb. 28, 2022 | AKBA | Employee Stock Option (Right to buy) | Common Stock | $2.16 | Feb. 28, 2032 | 225,000 | Acquired |
| Sept. 30, 2021 | AKBA | Employee Stock Option (Right to Buy) | Common Stock | $2.88 | Sept. 30, 2031 | 200,000 | Acquired |
| Feb. 26, 2021 | AKBA | Employee Stock Option (Right to buy) | Common Stock | $3.46 | Feb. 26, 2031 | 120,000 | Acquired |
| June 30, 2020 | AKBA | Employee Stock Option (Right to buy) | Common Stock | $13.58 | June 30, 2030 | 280,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $254,759 | · | · | · | $125,000 | · | $287,209 | $942,627 |
| 2021 | $473,871,237,077 | · | · | · | $234,170,184,000 | · | $7,496,707 | $17,214,772,804,498 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.